Pharmaceutical composition for treating recurrent oral ulceration, preparation and preparation method of pharmaceutical composition

A technology for recurrent oral ulcers, which is applied in the field of preparations and preparations, and pharmaceutical compositions for the treatment of recurrent oral ulcers. Anti-relapse effect

Inactive Publication Date: 2020-11-20
张红娟
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

If the medicine is wrong, the healing effect will not be good.
Therefore, there is no traditional Chinese medicine composition that can significantly alleviate the symptoms of patients with recurrent oral ulcers in the market at present.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The pharmaceutical composition for treating recurrent oral ulcers of the present invention includes raw materials, and the raw materials include the following components in terms of 100 g: Cortex Phellodendri 45 g, Amomum 30 g, Radix Glycyrrhizae 20 g, and Cinnamon 5 g.

[0028] The preparation method of the above-mentioned pharmaceutical composition for treating recurrent oral ulcer is as follows: the above-mentioned components are mixed, and ground into a fine powder of 120 meshes to make a powder.

[0029] Take 5g with warm water each time, three times a day, half an hour before breakfast, lunch and dinner respectively. Do not eat raw, cold and spicy food while taking the medicine.

Embodiment 2

[0031] The pharmaceutical composition for treating recurrent oral ulcers of the present invention includes raw materials, and the raw materials include the following components in terms of 110 g: Phellodendron cortex 50 g, Amomum 35 g, Radix Glycyrrhizae 20 g, and Cassia cinnamon 5 g.

[0032] The preparation method of the above-mentioned pharmaceutical composition for treating recurrent oral ulcer is the same as that of Example 1.

Embodiment 3

[0034] The pharmaceutical composition for treating recurrent oral ulcers of the present invention includes raw materials, and the raw materials include the following components in terms of 58g: Cortex Phellodendri 25g, Amomum 18g, Radix Glycyrrhizae 12g, and Cinnamon 3g.

[0035] The preparation method of the above-mentioned pharmaceutical composition for treating recurrent oral ulcer is as follows: weighing the above-mentioned components, first putting each component into a casserole, adding 1200ml of water and soaking for 0.5 hours. Then first boil it with strong fire (high fire), then boil it with slow fire (low fire) until 350-450ml is left, pour out the boiled medicinal liquid and place it in a clean container. Take it three times a day, taking 100-150ml half an hour before breakfast, lunch and dinner respectively. Do not eat raw, cold and spicy food while taking the medicine.

[0036] The beneficial effect of the present invention is that: the effective rate is 100% in ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for treating recurrent oral ulceration, a preparation and a preparation method thereof, the pharmaceutical composition comprises the following bulk drugs by weight: 40-50% of phellodendron, 25-35% of villous amomum fruit, 15-25% of honey-fried licorice root, and 3-10% of cassia bark. The preparation comprises the pharmaceutical composition fortreating recurrent oral ulceration and pharmaceutically acceptable auxiliary materials, the pharmaceutical composition for treating recurrent oral ulceration is used as an active ingredient. The pharmaceutical composition provided by the invention is precise and appropriate in formula, simple in medicine and high in effect, can effectively treat recurrent oral ulceration, and does not relapse after intermittent transition for half a year. The composition is a common traditional Chinese medicine conforming to national drug administration laws and regulations, is good in safety, free of toxic and side effects and convenient to use, and provides a new drug choice for clinic.

Description

technical field [0001] The invention relates to the field of drugs for treating recurrent oral ulcers, in particular to a pharmaceutical composition, a preparation and a preparation method for treating recurrent oral ulcers. Background technique [0002] Oral ulcer (commonly known as "mouth sore") is a common ulcerative injury disease that occurs in the oral mucosa. Among them, recurrent oral ulcer refers to the localized ulcer damage of oral mucosa that recurs periodically. It is characterized by repeated attacks and lingering and difficult to heal clinically. It can occur in any season, anywhere in the oral mucosa, single or multiple, and appears as oral mucosa Round or oval, shallow small ulcers are the main pathological manifestations, and burning pain is the main symptom. After encountering cold, hot, and irritating objects, the pain is obviously intensified. Recurrent oral ulcer is a common disease in the Department of Stomatology. At present, Western medicine has no ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9064A61P1/02
CPCA61K36/484A61K36/54A61K36/756A61K36/9064A61P1/02A61K2300/00
Inventor 施俊张红娟
Owner 张红娟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products